Evidence map›Paper›PMID 39456788›Full record

ArticleInternational journal of molecular sciences2024

Therapeutic Options for Crigler-Najjar Syndrome: A Scoping Review.

Vanessa Sambati, Serena Laudisio, Matteo Motta, Susanna Esposito

Abstract readScoping Review
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. [Expert consensus on the diagnosis and therapy of inherited hyperbilirubinemia (version 2025)].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Vanessa SambatiPediatric Clinic, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy.ORCID 0000-0002-1579-3934
Serena LaudisioPediatric Clinic, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy.
Matteo MottaPediatric Clinic, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy.
Susanna EspositoPediatric Clinic, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy.ORCID 0000-0003-4103-2837

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crigler-Najjar Syndrome (CNS) is a rare genetic disorder caused by mutations in the

Indexed as

Crigler-Najjar SyndromeGenetic TherapyLiver TransplantationGlucuronosyltransferaseHumansUGT1A1 EnzymeGlucuronosyltransferaseUGT1A1 EnzymeCrigler–Najjar syndromegene therapyhyperbilirubinemialiver transplantationUGT1A1 mutation

Identifiers

PMID39456788
PMCPMC11508002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.